Shopping Cart
Remove All
Your shopping cart is currently empty
HLA-A*02:01&B2M&TERT (ILAKFLHWL) Monomer Protein, Human, MHC (His & Avi), Biotinylated
(Synonyms: TERT, ILAKFLHWL) Copy Product InfoSynonyms: TERT, ILAKFLHWL
Catalog No. TMPK-01920 Copy Product Info
HLA-A*02:01&B2M&TERT (ILAKFLHWL) Monomer Protein, Human, MHC (His & Avi), Biotinylated is expressed in HEK293 Cells. The accession number is A0A140T913(HLA-A*02:01)&P61769(B2M)&ILAKFLHWL.
Customer service consultation
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 µg | $133 | 7-10 days | 7-10 days | |
| 20 µg | $198 | 7-10 days | 7-10 days | |
| 50 µg | $377 | 7-10 days | 7-10 days | |
| 100 µg | $598 | 7-10 days | 7-10 days | |
| 200 µg | $948 | 7-10 days | 7-10 days | |
| 500 µg | $1,760 | 7-10 days | 7-10 days |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Bioactivity | Activity has not been tested. It is theoretically active, but we cannot guarantee it. |
| Description | HLA-A*02:01&B2M&TERT (ILAKFLHWL) Monomer Protein, Human, MHC (His & Avi), Biotinylated is expressed in HEK293 Cells. The accession number is A0A140T913(HLA-A*02:01)&P61769(B2M)&ILAKFLHWL. |
| Species | Human |
| Expression System | HEK293 Cells |
| Tag | C-His-Avi |
| Accession Number | A0A140T913(HLA-A*02:01)&P61769(B2M)&ILAKFLHWL |
| Construction | Gly25-Thr305 (HLA-A*02:01), Ile21-Met119 (B2M) and ILAKFLHWL peptide |
| Protein Purity | > 95% as determined by Bis-Tris PAGE; > 95% as determined by HPLC |
| Endotoxin | < 1 EU/μg of the protein as determined by the LAL method. |
| Formulation | Supplied as 0.22 μm filtered solution in PBS (pH 7.4). |
| Synonyms | TERT, ILAKFLHWL |
| Research Background | The human telomerase catalytic subunit human telomerase reverse transcriptase (hTERT) is expressed in many human cancer cells derived from multiple tissues, but infrequently in normal cells. Thus, hTERT is an attractive candidate target for tumor immunotherapy. hTERT:540–548 peptide (p540, ILAKFLHWL) has been identified as an effective HLA-A*0201-restricted T-cell epitope, an effective T-cell-based cancer treatment, including vaccines, against hTERT will likely require the identification of other MHC class I-restricted epitopes in this antigen. |
| Molecular Weight | 50.60 kDa (Predicted); 52-62 kDa (Reducing condition, due to glycosylation) |
| Shipping | In general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice. |
| Storage | It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Recombinant Proteins
Preview
Related Tags: HLA-A*02:01&B2M&TERT (ILAKFLHWL) Monomer Protein, Human, MHC (His & Avi), Biotinylated chemical structure | HLA-A*02:01&B2M&TERT (ILAKFLHWL) Monomer Protein, Human, MHC (His & Avi), Biotinylated molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.